Cullen G. Taylor

Cullen Taylor helps companies structure and negotiate their most complex commercial transactions, particularly those involving the development, acquisition, and commercialization of intellectual property and technology. Cullen takes a practical, results-oriented approach to getting deals done, drawing on his broad experience across multiple industries to anticipate and address problems before they arise.

Trained as an intellectual property lawyer, Cullen understands the technical and business issues that arise as parties enter, live under, and exit long-term commercial arrangements. Cullen is skilled at structuring and drafting contracts that address these concerns while keeping the client's business goals at front and center.

Cullen focuses his practice primarily on the life sciences industry, where he handles a variety of transactions, including product acquisition, licensing, research and development, collaboration, co-promotion, supply, and distribution agreements. His clients include pharmaceutical and biotechnology companies and device and diagnostics manufacturers with products and therapies at all stages of development. Cullen is often called upon to advise such clients on discovering, developing, and acquiring cutting-edge therapies and innovative technologies.

Cullen is Co-Head (Americas) of the firm's Life Sciences Transactions team. He regularly collaborates with his colleagues in the firm's Corporate practice to address intellectual property and technology-related issues that arise in mergers, acquisitions, and other corporate transactions.

Cullen was recently recognized by Managing IP as the 2021 IP Transactional Lawyer of the Year for the Americas.